middle.news
How Anatara’s New Japanese Patent Boosts Its Gastrointestinal Health Ambitions
9:29am on Wednesday 9th of July, 2025 AEST
•
Healthcare
Read Story
How Anatara’s New Japanese Patent Boosts Its Gastrointestinal Health Ambitions
9:29am on Wednesday 9th of July, 2025 AEST
Key Points
Japanese patent granted for GaRP gastrointestinal health composition
Anti-Obesity pre-clinical studies enter treatment challenge phase
GaRP-IBS trial shows safety and symptom improvements in IBS patients
R&D Tax Incentive application registered for 2024-2025 income period
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anatara Lifesciences (ASX:ANR)
OPEN ARTICLE